academic article

• Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study..  The Lancet. Respiratory medicine.  9:733-746. 2021
• Advancement of global health: Recommendations from the Global Advisory Panel on the Future of Nursing & Midwifery (GAPFON®)..  Journal of advanced nursing.  76:741-748. 2020